Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $690.0 million.

  • Integra Lifesciences Holdings' Treasury Shares fell 25.8% to $690.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $690.0 million, marking a year-over-year decrease of 25.8%. This contributed to the annual value of $691.4 million for FY2024, which is 681.46% up from last year.
  • Integra Lifesciences Holdings' Treasury Shares amounted to $14.4 million in Q3 2025, which was down 26.29% from $14.4 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' 5-year Treasury Shares high stood at $14.5 million for Q3 2024, and its period low was $4.9 million during Q1 2021.
  • For the 5-year period, Integra Lifesciences Holdings' Treasury Shares averaged around $9.9 million, with its median value being $9.5 million (2023).
  • As far as peak fluctuations go, Integra Lifesciences Holdings' Treasury Shares tumbled by 32.95% in 2021, and later surged by 7836.87% in 2023.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Treasury Shares stood at $234.4 million in 2021, then surged by 54.79% to $362.9 million in 2022, then soared by 78.37% to $647.3 million in 2023, then rose by 6.81% to $691.4 million in 2024, then dropped by 0.2% to $690.0 million in 2025.
  • Its Treasury Shares stands at $690.0 million for Q3 2025, versus $690.0 million for Q2 2025 and $690.4 million for Q1 2025.